Tag
Ritu Mittal
2 articles
Suraksha Diagnostics Q2 PAT Up 69% YoY
Suraksha Diagnostic reported unaudited Q2 FY27 standalone and consolidated results with PAT growth of 69% YoY to ₹149.50 million.
EBITDA grew 45% YoY to ₹363.17 million with margin expansion to 36.7%
Suraksha Diagnostics Q2 PAT Up 69% YoY
Suraksha Diagnostic Limited reported unaudited Q2 FY27 standalone and consolidated financial results with PAT surging 69% YoY to ₹149.50 million.
Total income grew 26% YoY to ₹1,005.75 million in Q2 F